described in other species with lipid mobilization disorders. As with the affected bison in the present study, fatal hepatic lipidosis has been recently described in obese bison in late gestation; therefore, obesity during late gestation should also be included as a key factor in the development of fatal hepatic lipidosis in bison (Berezowski J, Simko E, Feist M, Haigh J, Woodbury M: 2001, Fat bison syndrome: a report of fatal hepatic lipidosis in obese, late pregnant bison (Bison bison) cows. Proc Am Assoc Vet Lab Diagn: 17.) A disease syndrome associated with excessive lipid mobilization and hepatic lipidosis has not been previously identified in bison. These findings suggest that pregnant bison are susceptible to such a syndrome. Although the bison in the current report were exposed to various unique stressors that are not present in commercial bison captive herds, bison producers and veterinarians should be aware of the potential for such changes and monitor feeding of pregnant bison as well as potential stressors that could initiate anorexia and negative energy balance situations. described in Canada in 1991 (Clark EG: 1997, Proc Am Assoc Swine Pract: 499-501; Harding JCS: 1997, Proc Am Assoc Swine Pract: 503) and has since been reported in many countries worldwide. 8, 17, 24, 30 The disease primarily affects pigs between the ages of 5 and 18 weeks and is clinically characterized by progressive weight loss, tachypnea, dyspnea, anemia, diarrhea, and jaundice. 13, 31 Characteristic microscopic lesions are lymphoid depletion, granulomatous interstitial pneumonia, hepatitis, and nephritis. 6, 12, 18, 27 Clinical PMWS was reproduced experimentally in some but not all of the cesarean-derived, colostrum-deprived pigs, 7,16 the gnotobiotic pigs, 11 the colostrum-deprived conventional pigs, 2, 18 or the conventional pigs 6 inoculated with PCV-2. All the gnotobiotic pigs infected with PCV-2 and injected with keyhole limpet hemocyanin in incomplete Freund's adjuvant developed lesions characteristic of PMWS, whereas those given only PCV-2 did not develop any lesions. 20 Commonly used vaccines such as bacterins for Mycoplasma hyopneumoniae and Actinobacilus pleuropneumoniae also showed evidence of enhancement of PCV-2 associated disease and lesions. 5, 22 Most recently, characteristic lymphoid and lung lesions of PMWS were reproduced in specific pathogen-free pigs inoculated with an infectious DNA clone of PCV-2; but the pigs did not exhibit wasting. 12 Several studies have demonstrated enhanced disease and lesions with experimental coinfection of PCV-2 and other infectious agents. Clinical signs of disease were more severe when pigs were coinfected with PCV-2 and porcine reproductive and respiratory syndrome virus (PRRSV), 3, 16 and PCV-2 replication was potentiated by PRRSV. 3, 28 PMWS also has been reproduced by coinfection of PCV-2 and porcine parvovirus (PPV) in colostrum-deprived pigs 2 and gnotobiotic pigs. 21 The objective of this retrospective survey was to examine which coinfecting agents are most commonly diagnosed with PCV-2 in field cases of PMWS submitted to a US diagnostic laboratory that receives swine cases from all over North America.
The presence of PCV-2 antigen in lymphoid tissues and/ or lung, demonstrated by immunohistochemistry (IHC), 32 together with moderate to severe lymphoid depletion and/or granulomatous lymphadenitis, was used as the criteria for the diagnosis of PMWS. PMWS was not diagnosed if lymphoid tissues were not submitted with the case. The presence of PRRSV and swine influenza virus (SIV) was confirmed by IHC, polymerase chain reaction (PCR), and/or virus isolation (VI). Mycoplasma hyopneumoniae was detected by fluorescent antibody (FA) or IHC, but characteristic microscopic lesions of moderate to severe peribronchiolar and perivascular lymphoid hyperplasia were considered diagnostic of M. hyopneumoniae-induced pneumonia despite a neg-ative FA or IHC test for M. hyopneumoniae. The isolation of bacterial agents was performed by routine culture procedures. A Kolmogorov-Smirnov test a was used to determine if the age of the animals affected with PMWS followed a normal distribution.
A total of 4,688 submissions in which PCV-2 IHC had been performed between January 2000, and September 2001, were reviewed. Of these, 1,751 (37.3%) tested positive for PCV-2, and 484 (10.3%) were diagnosed as PMWS. Approximately 80% of the cases were received from Iowa. The rest, in decreasing order, were from North Carolina, Oklahoma, Minnesota, Indiana, Ohio, Colorado, Illinois, Michigan, Kansas, Missouri, Utah, Wisconsin, and Virginia.
Of all the animals that tested positive for PCV-2 antigen by IHC, lymphoid lesions characteristics of PMWS were confirmed in only 484 out of 1,751 (27.6%); but lymphoid tissues were not submitted from many of the cases, and thus PMWS could not be ruled out or confirmed in those cases. The number of cases having each of the different combinations of pathogens is illustrated in Fig. 1 . Coinfection of PCV-2 ϩ PRRSV was the most common combination with 164 cases. In decreasing order, other coinfections were PCV-2 ϩ M. hyopneumoniae (92 cases), PCV-2 ϩ PRRSV ϩ M. hyopneumoniae (77 cases), PCV-2 ϩ bacterial septicemia (68 cases), PCV-2 ϩ bacterial pneumonia (37 cases), and PCV-2 ϩ SIV (13 cases). There were only 9 cases in which singular PCV-2 infection was confirmed without any coinfecting pathogens. The total prevalence of coinfection with PCV-2 was 51.9% for PRRSV, 35.5% for M. hyopneumoniae, 14.0% for bacterial septicemia, 7.6% for bacterial pneumonia, 5.4% for SIV, and 1.9% for PCV-2 alone.
The types of bacterial pathogens isolated for each of the combinations of PCV-2 ϩ bacterial septicemia and PCV-2 ϩ bacterial pneumonia are illustrated in Figs. 2, 3 . The most common bacterial septicemia was Streptococcus suis followed by Salmonella sp. Bacterial pneumonias were primarily caused by Pasteurella multocida.
Ages were provided in 369 of the 484 cases. Among these cases, PMWS primarily occurred between 8 and 18 weeks of age (294/369), with the highest number of cases occurring at 10 weeks of age. The corresponding histogram followed a normal distribution curve according to the Kolmogorov-Smirnov test (P Ͼ 0.2) ( Fig. 4) . Interestingly, there were 8 cases in which PMWS was diagnosed at Յ5 weeks of age. Coinfection was with PRRSV was found in 6 of these 8 cases.
In some of the PCV-2-positive cases, PMWS confirmation was not possible if lymphoid tissue was not submitted; so the 27.6% is likely a low estimate of the percentage of PCV-2-infected pigs that develop PMWS. In the present survey the prevalence of PMWS was 10.3% (484 cases of PMWS out of 4,868 cases examined), which is very close to the 8.1% (133 cases of PMWS out of 1,634 cases examined) found in a South Korean study during 1999 and 2000, 19 and the 12.9% (7 cases of PMWS out of 59 cases examined) reported in a Canadian study carried out in 1998. 23 The fact that many different infectious agents were isolated in cases of PMWS strongly supports the idea that a variety of pathogens may share a common mechanism in stimulating the immune system, 5, 20 with subsequent progression of PCV-2 infection to PMWS. Alternatively, PCV-2 may make pigs more susceptible to other pathogens. The pathogens commonly involved in porcine respiratory disease complex (PRDC), PRRSV, and M. hyopneumoniae were the most common agents that coexisted with PCV-2 in cases of PMWS. PRRSV ϩ PCV-2 coinfection was found in 52% of the cases of PMWS, which is considerably higher than the 29.3% reported in South Korea, 19 more than double the 20% reported in one Canadian field case study, 1 and less than the 67% of the cases with PCV-2 ϩ PRRSV coinfection reported in another Canadian study. 23 European field studies [25] [26] [27] also confirm that PRRSV is involved in many farms with PMWS.
In a recent survey 15 the prevalence of PCV-2 and other pathogens in cases of PRDC received at the Iowa State University Veterinary Diagnostic Laboratory, Ames, Iowa, in the year 2000 was studied, and PCV-2 ϩ PRRSV was demonstrated in 56% of the cases, PCV-2 ϩ M. hyopneumoniae in 19%, and PCV-2 ϩ SIV in 12%. PRRSV was the most prevalent coinfecting agent associated with PCV-2 in swine pneumonia cases, with a percentage very similar to that found in the cases of PMWS in this study. The percentage of PRDC cases with PCV-2 ϩ M. hyopneumoniae coinfec- tion was lower and the percentage of PRDC cases with PCV-2 ϩ SIV coinfection was higher than those observed in PMWS cases in this study.
Porcine parvovirus has been used as a model coinfecting agent with PCV-2 to induce PMWS in experimental studies. 2, 18, 21 PPV was demonstrated by IHC and PCR in about 18% of the cases of PMWS in Canada 9 and by in situ hybridization in 25.6% of the cases of PMWS examined in South Korea. 19 Only one of the cases of PMWS in this survey was positive for PPV, but tests for PPV were conducted in only 8 out of 484 cases (5 by FA and 3 by VI). Increased testing of PMWS cases for PPV coinfection is warranted on the basis of the experimental models that clearly demonstrate enhanced clinical signs and lesions typical of PMWS in PCV-2 ϩ PPV-coinfected pigs.
The most prevalent bacterial coinfection with PCV-2 in this survey was PCV-2 ϩ S. suis in 5.5% of the cases. The combination of PCV-2 ϩ Haemophilus parasuis was diagnosed in only 1.6% of the cases; but in a recent South Korean study 19 PCV-2 ϩ H. parasuis was the most prevalent bacterial coinfection and was found in 32.3% of the PMWS cases.
It was not possible to determine the vaccination status of the PMWS cases in this survey because the case histories provided often did not include vaccination protocols. There is experimental evidence that common vaccines may trigger PCV-2 infection and cause it to progress toward PMWS and that vaccination could potentiate PCV-2 replication. 5, 22 A recent field trial supports the hypothesis that vaccine or druginduced immuno-modulation can potentiate the effects of PCV-2 infection, 22 but the risk of not using vaccines to minimize the effects of coinfections such as M. hyopneumoniae may be greater than the risk of vaccination-induced PMWS.
The age of presentation of PMWS followed a normal distribution and coincides with the data from other reports. 10, 14, 19 It is uncommon in the US to find PMWS in animals less than 5 weeks of age. In all the 8 cases of PMWS in pigs Յ5 weeks of age presented here, other coinfecting agents such as PRRSV were present in addition to PCV-2. Such findings suggest that these pigs have a lack or early loss of maternal immunity against PCV-2 and/or that coinfecting agents such as PRRSV induced increased replication of PCV-2 and earlier development of PMWS.
Perhaps, the strongest argument for the necessity of a coinfection or other cofactors 25 for full development of the pathogenic potential of PCV-2 (whether in PMWS or PRDC) is the low percentage of cases in which PCV-2 is found alone (only 1.9% in this study). In a similar South Korean study 19 [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , the percentage of cases in which they are the only agents found is much higher (39.8% of the PRRSV cases and 36.9% of the SIV cases).
Proven protocols for management and prevention of PMWS are not yet established. There is no PCV-2 vaccine to date. At this point in time, veterinarians often recommend thorough sanitation between groups with the use of disinfectants effective against PCV-2, 29 all-in-all-out pig flow, and controlling farm-specific coinfecting agents that may account for progression of PCV-2 infection to PMWS. This survey confirms that in the US, PRRSV and M. hyopneumoniae are the most common coinfections in cases of PCV-2-associated PMWS. At least 2 experimental reports 3,28 support PRRSV-induced increased replication of PCV-2 and increased incidence of PMWS in PCV-2 ϩ PRRSV-coinfected pigs. Because more than half the cases of PMWS in our study were associated with PRRSV infection, an effective PRRSV control or eradication program may be important in reducing the incidence of PMWS in US herds.
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